Just three days into the Paralympics and Canada have secured six medals! To congratulate Canada’s medals, we are continuing with the Arthritis Olympics Challenge. Today’s Arthritis Olympics Challenge: Go on a photo walk! To follow the Canadian Paralympic Team’s progress, please visit CBC’s Paralympics page here.
Making arthritis news: Sharing the consumer perspective through the Arthritis Broadcast Network Booth
Arthritis Consumer Experts (ACE) will be in Whistler, BC to attend the 2014 CRA Annual Scientific Meeting & AHPA Annual Meeting. The meetings, which begin today and end on Saturday March 1, brings rheumatologist and arthritis health professionals (like physiotherapists) from all over Canada together to learn about and share the latest advances in arthritis research and care.
ACE and representatives from the Canadian Arthritis Patient Alliance, the Consumer Advisory Board of the Arthritis Research Centre of Canada, the BC Lupus Society, the Canadian Spondylitis Association and Patient Partners will be there to share the arthritis consumer perspective. You can keep up-to-date on our activities by following us on Facebook or join the conversation on Twitter using #CRArthritis14.
While there, ACE and representatives will be interviewing rheumatologists (doctors who specialize in treating arthritis) and other arthritis-health related topic presenters about their views on the state of arthritis in Canada. The issues we will be talking to the meeting participants about will include:
- The highlights of this year’s CRA meeting that would benefit patients most;
- The use of social media in relation to patient care and medical research;
- Advances in the treatment of arthritis; and,
- Other important topics related to arthritis health.
If you have any questions you would like ACE to ask the rheumatologist regarding the state of arthritis healthcare in Canada, please send your questions to firstname.lastname@example.org and we will include them in the interviews. For more information regarding the meeting, please click here.
The Spondyloarthritis Research Consortium of Canada (SPARCC) and the Canadian Spondylitis Association (CSA) are pleased to announce an upcoming patient forum on ankylosing spondylitis (AS).
Patients with AS and a family member are invited to attend this free informational event. Lectures and activities include:
- Current concepts on the cause of AS.
- Update on the medical treatment of AS.
- Information non-pharmacologic treatment of AS.
- Ask the experts.
Contact Maria Morales at email@example.com or call 416-603-5800, or complete the registration form, which can be found below. The registration form is also available at www.sparccc.ca and www.spondylitis.ca.
Our friend and an avid arthritis advocate Dawn Richards will be doing an interview in 30 minutes with CHRY Radio 105.5FM at 5:15pm Eastern Standard Time (EST) to discuss invisible disabilities in the workplace. Join Dawn and learn about how invisible disabilities and diseases such as arthritis can affect your workplace. Tune in to 105.5FM or listen live on http://chry.fm.
So far in 2014, Health Canada has issued Notices of Compliance (NOCs) for certolizumab pegol (Cimzia®) for the treatment of psoriatic arthritis (January 2) and for the treatment of ankylosing spondylitis (January 15), and ustekinumab (Stelara®) for the treatment of psoriatic arthritis (January 21). Continue reading
The Yukon recently added two medications to its Drug Formulary: denosumab (Prolia®) for osteoporosis and tocilizumab (Actemra®) for rheumatoid arthritis. Both medications are considered an Exception drug under the Pharmacare (seniors plan) and the Chronic Disease Program, which requires an application for the Formulary Working Group to assess. Continue reading